✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹21 Cr.
P/E
59.54
  • Bacil Pharma
  • Phaarmasia
  • Ishita Drugs & Inds.
FAQs on Bacil Pharma Ltd. Shareprice

Bacil Pharma has given better returns compared to its competitors.
Bacil Pharma has grown at ~204.06% over the last 1yrs while peers have grown at a median rate of 7.0%

There is insufficient historical data to gauge this.
Latest PE of Bacil Pharma is 60.74

Growth Table
  • Bacil Pharma Ltd.
  • Phaarmasia
  • Ishita Drugs & Inds.
Balance Sheet
  • Bacil Pharma Ltd.
  • Phaarmasia
  • Ishita Drugs & Inds.
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Bacil Pharma Ltd.
  • Phaarmasia
  • Ishita Drugs & Inds.
Cash Flow
  • Bacil Pharma Ltd.
  • Phaarmasia
  • Ishita Drugs & Inds.
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Bacil Pharma Ltd.
  • Phaarmasia
  • Ishita Drugs & Inds.
Quarterly Results
  • Bacil Pharma Ltd.
  • Phaarmasia
  • Ishita Drugs & Inds.
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Bacil Pharma Ltd. Financials

Bacil Pharma balance sheet is weak and might have solvency issues

Yes, The debt of Bacil Pharma is increasing.
Latest debt of Bacil Pharma is ₹0.05 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹0.05 Crs.

Yes, profit is increasing.
The profit of Bacil Pharma is -₹0.06 Crs for Mar 2024, -₹0.1 Crs for Mar 2023 and -₹3.86 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bacil Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech